Are Psychedelics Medicine? It’s Complicated
Written by Joseph Santiago
Ask someone who’s had a real psychedelic experience whether it was “medicine,” and you’ll usually get a pause before the answer. Not because they’re unsure it helped them, plenty of people will tell you it did, but because “medicine” feels like too small a word for what happened.
That gap is worth sitting with. Psychedelics are having a mainstream moment right now, and the word “medicine” is doing a lot of the heavy lifting in that conversation. It’s the word that gets them taken seriously, funded, researched, decriminalized. But is it actually the right word, or just the most convenient one?
What we mean by “medicine”
Strip it down and medicine is really about two things: a practice (what a doctor does) and a substance (what you take). Either way, it exists in relation to a problem. You take medicine because something’s wrong, or because you’re trying to keep something from going wrong.
Take away the problem, and medicine doesn’t really have a job to do anymore.
That’s the frame most people are working from when they talk about “psychedelic medicine.” And it’s not wrong, exactly. It’s just incomplete.
What psychedelics actually are
The word “psychedelic” comes out of a 1950s letter exchange between psychiatrist Humphry Osmond and writer Aldous Huxley. Osmond later coined it formally. It’s built from two Greek roots: psyche (mind) and dēloun (to reveal). Mind-revealer. Not mind-fixer.
That distinction matters. Psychedelics, LSD, psilocybin, mescaline, DMT, ketamine, MDMA, Salvia divinorum, share a knack for stripping away the usual defenses the mind runs on, sometimes to the point of full ego dissolution at higher doses. People come out the other side describing it as anywhere from unsettling to genuinely life-altering. What ties the category together isn’t just the visuals or the altered perception. It’s the insight that tends to come with it.
So, are they medicine?
They can be. They’re also something bigger than that, and treating them as medicine-and-nothing-else undersells what they do.
Fun counts for something. Sociologist Ben Fincham made this case in The Sociology of Fun (2017). Fun gets treated as frivolous in a culture obsessed with productivity, even though most of us know, somewhere, that it’s not optional. It’s part of a good life, not a reward tacked onto the end of one. A psychedelic trip is, for most people, genuinely enjoyable. That alone should complicate the “it’s medicine” framing, because medicine isn’t built to be fun. It’s built to fix things, and ideally you’d rather not need it.
They take you past baseline, not back to it. Medicine returns you to normal. Psychedelics do the opposite. The whole point, for a lot of people, is going somewhere past ordinary sober consciousness. A healthy, happy person can take a psychedelic and walk away with something real from it. That’s not really true of medicine in the conventional sense, even the preventative kind.
The trip has value on its own terms. Whether you think of it as mystical or just an unusual, temporary state of mind, very few people who’ve had a good trip come away thinking less of it. Tripping might carry therapeutic weight, sure, but reducing it to a side effect of treatment misses what makes it rare in the first place.
Where the medicine really shows up
None of this is a case against the therapeutic side. It’s a real, growing body of research, and it deserves to be taken seriously on its own.
Depression. Psilocybin has the most consistent evidence here. A Johns Hopkins study found antidepressant effects lasting up to a year in a majority of participants. It was a small trial (27 people), so it’s not the final word, but it fits a pattern showing up across other research too. The leading theory involves the 5-HT2A serotonin receptor: psychedelics bind there like serotonin does, but appear to also cross into the neuron itself rather than stopping at the receptor, which may be what drives their outsized effect on neural plasticity.
Addiction. The research here is younger, but the mechanisms being studied echo the depression findings: induced neuroplasticity, changes in brain network connectivity, shifts in reward and emotional processing, and the insight that comes out of the experience itself, all potentially working together to help people genuinely change their relationship with a substance. (Bogenschutz & Pommy, Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action, 2022).
Psychedelics can be medicine. They just don’t stop there. They also hand people fun, insight, and an experience that has nothing to do with treating anything, which is exactly why they deserve their own category, not a subheading under “pharmaceuticals.”
Continue your journey
If you’re curious about exploring psychedelics responsibly, choosing the right variety makes a real difference. At Microdose Bros, we hand-select everything we sell and put real effort into the educational side too.
New to microdosing? The McMicrodose Starter Kit uses beginner-friendly Mexicana truffles.
Want something gentle? Mexicana Magic Truffles are one of our most approachable options for first-timers.
Looking for balance? Atlantis Magic Truffles are a favorite for self-reflection and creativity.
Experienced? High Hawaiians Magic Truffles are among our strongest, for those who know what they’re doing.
Browse the full shop for truffles, grow kits, and more.
Follow Microdose Bros
For more guides, product updates, and honest conversations about psychedelics and microdosing, follow us on social media:
📸 Instagram https://www.instagram.com/microdosebros
📘 Facebook https://www.facebook.com/microdosebros
🎵 TikTok https://www.tiktok.com/@microdosebros
Psychedelics aren’t for everyone. Know your local laws, prioritize set and setting, and use responsibly. This article is educational, not medical advice.
